People
Matthew Moyer
Director of Clinical Supply Technology
- Overview
TCS is here to make a difference through technology.
Leading the way in innovation for over 50 years, we build greater futures for businesses across multiple industries and 131 countries.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
- Overview
We’re in it for good, driving positive change for the benefit of all.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
-
About Us
-
Leadership
-
In the news
-
Events
- Overview
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Customer Stories
-
Perspectives
-
Global studies
-
Topics
- Overview
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
- Overview
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Top Results
Showing
10
01 - 07
Matt works as a Director of Clinical Supply Technology at Merck. Having possessed an overall 20 years of pharmaceutical experience with 17 years at Merck, Matt has worked across diverse areas including analytical development, packaging and Clinical Suppl Operations (CSO). In the current role, he leads the incorporation of innovative clinical supply and clinical trial technologies to improve supply production, trial execution, patient engagement, and decision making in Merck clinical trials. Matt is also responsible for enabling global readiness of new CSO facilities, equipment, technologies, and processes, ensuring Merck meets evolving business dynamics for quality and safety, and improving supply production and distribution. In addition to the Merck responsibilities, from 2017-2019, Matt led the TransCelerate Patient Technology team to enable and accelerate clinical trial use of patient-facing digital technology, leading to richer, more objective data collection and enhanced patient experience.
Matt is a certified Project Management Professional (PMP) and has earned a BS in Chemistry from Albright College, an MS in Pharmaceutics from Temple University, an MBA from Lehigh University.
Matthew Moyer's articles
©2022 TATA Consultancy Services Limited